<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">kpccz</journal-id><journal-title-group><journal-title xml:lang="ru">Комплексные проблемы сердечно-сосудистых заболеваний</journal-title><trans-title-group xml:lang="en"><trans-title>Complex Issues of Cardiovascular Diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2306-1278</issn><issn pub-type="epub">2587-9537</issn><publisher><publisher-name>Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17802/2306-1278-2021-10-2S-83-88</article-id><article-id custom-type="elpub" pub-id-type="custom">kpccz-931</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ ДОКЛАДЧИКОВ КОНФЕРЕНЦИИ</subject></subj-group></article-categories><title-group><article-title>«Портрет» пациентов c легочной гипертензией на фоне приобретенного порока митрального Клапана сердца до хирургической коррекции</article-title><trans-title-group xml:lang="en"><trans-title>"Portrait" of patients with pulmonary hypertension, associated with mitral valve diseases before cardiac surgery</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7549-8075</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Теплова</surname><given-names>Ю. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Teplova</surname><given-names>Yu. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант по специальности «кардиология», лаборант-исследователь лаборатории пороков сердца  отдела хирургии сердца и сосудов,</p><p>Сосновый бульвар, 6, Кемерово, 650002</p></bio><bio xml:lang="en"><p>postgraduate student in "Cardiology", laboratory assistant-researcher at the laboratory of Valvular Heart Disease, the Department of Heart and Vessel Surgery, </p><p>6, Sosnoviy Blvd., Kemerovo, 650002</p></bio><email xlink:type="simple">TeplovaJulya@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4649-5921</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ляпина</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Lyapina</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук научный сотрудник лаборатории реабилитации отдела клинической  кардиологии, врач-кардиолог отделения хирургического лечения сложных нарушений ритма сердца и  электрокардиостимуляции,</p><p>Сосновый бульвар, 6, Кемерово, 650002</p></bio><bio xml:lang="en"><p>Phd, a research assistant at the Rehabilitation Laboratory, the Department of Clinical Cardiology, Cardiologistat the Department of Surgical Treatment of Complex Cardiac Arrhythmias and Electrocardiostimulation, </p><p>6, Sosnoviy Blvd., Kemerovo, 650002</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3221-659X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шалева</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shaleva</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант по специальности «кардиология», врач-кардиолог клинико-диагностического отделения,</p><p>Сосновый бульвар, 6, Кемерово, 650002</p></bio><bio xml:lang="en"><p>postgraduate student in "Cardiology", cardiologist at the clinical and diagnostic department,</p><p>6, Sosnoviy Blvd., Kemerovo, 650002</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0154-323X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузьмина</surname><given-names>О. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuzmina</surname><given-names>O. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук младший научный сотрудник лаборатории пороков сердца отдела хирургии сердца и сосудов,</p><p>Сосновый бульвар, 6, Кемерово, 650002</p></bio><bio xml:lang="en"><p>PhD, a junior research assistant at the laboratory of Valvular Heart Disease, the Department of Heart and Vessel Surgery, </p><p>6, Sosnoviy Blvd., Kemerovo, 650002</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Евтушенко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Evtushenko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук заведующий лабораторией пороков сердца отдела хирургии сердца и сосудов,</p><p>Сосновый бульвар, 6, Кемерово, 650002</p></bio><bio xml:lang="en"><p>Ph.D., Head of the Laboratory of Valvular Heart Disease, Department of Heart and Vessel Surgery, </p><p>6, Sosnoviy Blvd., Kemerovo, 650002</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4642-3610</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барбараш</surname><given-names>О. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Barbarash</surname><given-names>O. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>член-корреспондент РАН, доктор медицинских наук, профессор директор,</p><p>Сосновый бульвар, 6, Кемерово, 650002</p></bio><bio xml:lang="en"><p>Ph.D., Professor, Corresponding Member of the Russian Academy of Sciences, Director,</p><p>6, Sosnoviy Blvd., Kemerovo, 650002</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Федеральное государственное бюджетное научное учреждение «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний»<country>Россия</country></aff><aff xml:lang="en">Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>04</day><month>09</month><year>2021</year></pub-date><volume>10</volume><issue>2</issue><issue-title>приложение</issue-title><fpage>83</fpage><lpage>88</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Теплова Ю.Е., Ляпина И.Н., Шалева В.А., Кузьмина О.К., Евтушенко А.В., Барбараш О.Л., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Теплова Ю.Е., Ляпина И.Н., Шалева В.А., Кузьмина О.К., Евтушенко А.В., Барбараш О.Л.</copyright-holder><copyright-holder xml:lang="en">Teplova Y.E., Lyapina I.N., Shaleva V.A., Kuzmina O.K., Evtushenko A.V., Barbarash O.L.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nii-kpssz.com/jour/article/view/931">https://www.nii-kpssz.com/jour/article/view/931</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить «портрет» больных приобретенным пороком митрального клапана (МК) различного генеза и легочной гипертензией, госпитализированных для хирургической коррекции патологии.</p><p>Материалы и методы В исследование включены 97 пациентов с приобретенными пороками МК и легочной гипертензией. Оценены демографические, клинико-анамнестические данные, показатели трансторакальной эхокардиографии, качества жизни до коррекции порока МК. Результаты Исследуемая когорта представлена в большей степени больными женского пола (n = 70; 72,2%). Чаще всего причиной порока МК была ревматическая болезнь сердца (n = 40; 41,2%). Избыточная масса тела, гипертоническая болезнь (n = 76; 78,4%) и фибрилляция предсердий (n = 62; 63,9%) – наиболее частые сопутствующие патологии. Уровень среднего давления в легочной артерии по данным эхокардиографии составил 35,5 (29,0; 40,0) мм рт. ст., значимо не различаясь у пациентов независимо от этиологии митрального порока. Менее выраженное ремоделирование левого желудочка отмечено у лиц с ревматической болезнью сердца, что обусловлено поражением МК по типу стеноза, по сравнению с пациентами с синдромом соединительно-тканной дисплазии или на фоне отрыва хорд МК, имеющих поражение МК в виде его недостаточности. Значимых различий в систолической функции правого желудочка в зависимости от этиологии порока МК не выявлено.</p></sec><sec><title>Заключение</title><p>Заключение. «Портрет» пациента с легочной гипертензией, ассоциированной с приобретенным пороком МК до его коррекции, включает: преобладание женского пола, избыточную массу тела, II–III функциональный класс хронической сердечной недостаточности, более частый ревматический генез порока МК, наличие сопутствующей патологии в виде гипертонической болезни и персистирующей формы фибрилляции предсердий, увеличенные размеры левого предсердия и левого желудочка, сниженную систолическую функцию правого желудочка по данным эхокардиографии. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To study “the portrait” of patients with acquired mitral valve (MV) heart disease of various origins and pulmonary hypertension hospitalized for surgical correction of the defect.</p></sec><sec><title>Methods</title><p>Methods. The study included 97 patients with acquired diseases of mitral valve and pulmonary hypertension. The assessment of demographic, clinical and anamnestic data, indicators of transthoracic echocardiography, quality of life before the correction of MV defect was carried out.</p></sec><sec><title>Results</title><p>Results. The studied cohort is mostly represented by female patients (n = 70; 72.2%). The most common cause of mitral valve disease was rheumatic heart disease (n = 40; 41.2%). Overweight, hypertension (n = 76; 78.4%) and atrial fibrillation (n = 62; 63.9%) were the most common comorbidities. The mean pressure level in the pulmonary artery according to echocardiography was 35.5 (29.0; 40.0) mm Hg, with no significant difference among the patients, regardless the mitral defect etiology. Less pronounced remodeling of the left ventricle was noted in patients with rheumatic heart disease, which is caused by a lesion of the MV by the type of stenosis in contrast to patients with connective tissue dysplasia syndrome or against the background of detachment of MV chords with MV damage in the form of its insufficiency. There were no significant differences in the systolic function of the right ventricle depending on the etiology of MV defect.</p></sec><sec><title>Conclusion</title><p>Conclusion. The “portrait” of a patient with pulmonary hypertension associated with an acquired mitral valve defect before its correction is the predominance of female, overweight, with II or III functional class of chronic heart failure, more frequent rheumatic genesis of MV defect, the presence of concomitant pathology in the form of hypertension and persistent atrial fibrillation, and increased size of the left atrium and left ventricle, reduced systolic function of the right ventricle according to the data of Echocardiography. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>легочная гипертензия</kwd><kwd>приобретенный порок митрального клапана</kwd><kwd>кардиохирургическое лечение</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pulmonary hypertension</kwd><kwd>acquired mitral valve defect</kwd><kwd>cardiac surgery treatment</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Евразийские клинические рекомендации по диагностике и лечению легочной гипертензии. Евразийский кардиологический журнал. 2020. 1: 78-122. doi:10.24411/2076-4766-2020-10002</mixed-citation><mixed-citation xml:lang="en">Eurasian clinical guidelines on diagnosis and treatment of pulmonary hypertension. Eurasian heart journal. 2020. 1: 78- 122. doi:10.24411/2076-4766-2020-10002. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Российское кардиологическое общество. Клинические рекомендации Легочная гипертензия, в том числе хроническая тромбоэмболическая легочная гипертензия. Режим доступа: https://scardio.ru/content/Guidelines/2020/Clinic_rekom_LG.pdf (дата обращения 12/06/2021)</mixed-citation><mixed-citation xml:lang="en">Rossijskoe kardiologicheskoe obshchestvo. Klinicheskie rekomendacii Legochnaya gipertenziya, v tom chisle hronicheskaya tromboembolicheskaya legochnaya gipertenziya. Available at: https://scardio.ru/content/Guidelines/2020/Clinic_rekom_LG.pdf (accessed12.06.2021)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hoeper M.M., Humbert M., Souza R., Idrees M., Kawut S.M., Sliwa-Hahnle K., Jing Z.C., Gibbs J.S. A global view of pulmonary hypertension. Lancet Respir Med. 2016 Apr;4(4):306-22. doi: 10.1016/S2213-2600(15)00543-3.</mixed-citation><mixed-citation xml:lang="en">Hoeper M.M., Humbert M., Souza R., Idrees M., Kawut S.M., Sliwa-Hahnle K., Jing Z.C., Gibbs J.S. A global view of pulmonary hypertension. Lancet Respir Med. 2016 Apr;4(4):306-22. doi: 10.1016/S2213-2600(15)00543-3.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mehra P., Mehta V., Sukhija R., Sinha A.K., Gupta M., Girish M.P., Aronow W.S. Pulmonary hypertension in left heart disease. Arch Med Sci. 2019;15(1):262-273. doi: 10.5114/aoms.2017.68938</mixed-citation><mixed-citation xml:lang="en">Mehra P., Mehta V., Sukhija R., Sinha A.K., Gupta M., Girish M.P., Aronow W.S. Pulmonary hypertension in left heart disease. Arch Med Sci. 2019;15(1):262-273. doi: 10.5114/aoms.2017.68938</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Coutinho G.F., Antunes M.J. Surgery for mitral stenosis in patients with pulmonary hypertension: How far can we go? J Thorac Cardiovasc Surg. 2016;152(2):302-3. doi: 10.1016/j. jtcvs.2016.05.041.</mixed-citation><mixed-citation xml:lang="en">Coutinho G.F., Antunes M.J. Surgery for mitral stenosis in patients with pulmonary hypertension: How far can we go? J Thorac Cardiovasc Surg. 2016;152(2):302-3. doi: 10.1016/j.jtcvs.2016.05.041.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gopal D.M., Santhanakrishnan R., Wang Y.C., Ayalon N., Donohue C., Rahban Y., Perez A.J., Downing J., Liang C.S., Gokce N., Colucci W.S., Ho J.E. Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndrome. J Am Heart Assoc. 2015; 4:e001597. doi: 10.1161/JAHA.114.001597.</mixed-citation><mixed-citation xml:lang="en">Gopal D.M., Santhanakrishnan R., Wang Y.C., Ayalon N., Donohue C., Rahban Y., Perez A.J., Downing J., Liang C.S., Gokce N., Colucci W.S., Ho J.E. Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndrome. J Am Heart Assoc. 2015; 4:e001597. doi: 10.1161/JAHA.114.001597.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Obokata M., Reddy Y.N.V., Pislaru S.V., Melenovsky V., Borlaug B.A. Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation 2017;136:6–19. doi: 10.1161/CIRCULATIONAHA.116.026807.</mixed-citation><mixed-citation xml:lang="en">Obokata M., Reddy Y.N.V., Pislaru S.V., Melenovsky V., Borlaug B.A. Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation 2017;136:6–19. doi: 10.1161/CIRCULATIONAHA.116.026807.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Shah S.J., Katz D.H., Selvaraj S., Burke M.A., Yancy C.W., Gheorghiade M., Bonow R.O., Huang C.C., Deo R.C. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation 2015; 131:269–79. doi: 10.1161/CIRCULATIONAHA.114.010637.</mixed-citation><mixed-citation xml:lang="en">Shah S.J., Katz D.H., Selvaraj S., Burke M.A., Yancy C.W., Gheorghiade M., Bonow R.O., Huang C.C., Deo R.C. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation 2015; 131:269–79. doi: 10.1161/CIRCULATIONAHA.114.010637.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Guazzi M. Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives. CircHeart Fail 2014;7:367–77. doi: 10.1161/CIRCHEARTFAILURE.113.000823.</mixed-citation><mixed-citation xml:lang="en">Guazzi M. Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives. CircHeart Fail 2014;7:367–77. doi: 10.1161/CIRCHEARTFAILURE.113.000823.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Edmonston D.L., Parikh K.S., Rajagopal S., Shaw L.K., Abraham D., Grabner A., Sparks M.A., Wolf M. Pulmonary Hypertension Subtypes and Mortality in CKD. Am J Kidney Dis. 2020 May;75(5):713-724. doi: 10.1053/j.ajkd.2019.08.027</mixed-citation><mixed-citation xml:lang="en">Edmonston D.L., Parikh K.S., Rajagopal S., Shaw L.K., Abraham D., Grabner A., Sparks M.A., Wolf M. Pulmonary Hypertension Subtypes and Mortality in CKD. Am J Kidney Dis. 2020 May;75(5):713-724. doi: 10.1053/j.ajkd.2019.08.027</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
